Stella Pharma Corp. Hits Day High with 15.94% Surge in Stock Price

Stella Pharma Corp., a small-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a significant surge in its stock price, gaining 15.94% on March 17, 2026. The stock reached an intraday high of JPY 494.00, marking a notable performance against the backdrop of the Japan Nikkei 225, which saw a slight decline of 0.09% on the same day. Over the past month, Stella Pharma has shown a robust increase of 25.98%, while its weekly performance stands at 2.78%. Year-to-date, the stock has impressively risen by 136.45%, contrasting sharply with the Nikkei 225's modest gain of 6.68%. However, despite these short-term gains, the company faces challenges, including a negative return on equity and a concerning long-term growth trajectory, with operating profit declining at an annual rate of 234.76% over the last five years. Stella Pharma's market capitalization is currently JPY 8,066 million, and it operates with a price-to-book ratio of 2.78. As the company navigates its financial landscape, its recent stock performance highlights the volatility and complexities inherent in the biotechnology sector.